Government commits $25m to medicine safety research
The federal Government will invest $25 million in research to improve the safe use of medicines and medicines intervention by pharmacists.
Complementary medicines: Heart failure
Heart failure (HF), also referred to as congestive cardiac failure, is present in 1–2% of the Australian population.1 It is the end result of...
The impact of air pollution
Air pollution is making us sick according to local and global research, including a study linking exposure to air pollution with subsequent acute cardiac...
New COVID-19 case in Byron Bay means limited restrictions are back
Queensland recorded three new cases of COVID-19 today (31 March), as residents of Greater Brisbane wait to hear if they will spend the Easter break in lockdown.
Antimicrobial use up in disadvantaged areas
Antimicrobial medicines use declined in Australia from 2013 to 2018, but the country’s rate remains high by OECD standards, according to new research.
Efficacy of antiplatelets in deep venous thrombosis
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.
